2m 2m 2m 2m 2m 2m 2m
Neurocrine Biosc (NBIX)
NASDAQ
$144.99+$1.70 (+1.19%)
Price as of Oct 23, 2026 4:10 AM EDT- $14.4BMarket Cap
- -0.26%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Neurocrine Biosc (NBIX)
$144.99+$1.70 (+1.19%)
NBIX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $143.29 | ||
Change | +$1.98 (+1.40%) | ||
Open | $141.62 | ||
High | $143.83 | ||
Low | $140.75 | ||
Previous Close | $141.31 | ||
Volume | 1,244,553 | ||
30-Day Average Volume | 1,366,129 | ||
1-Week Change | 4.63% | ||
1-Month Change | 0.73% | ||
1-Year Change | -0.26% | ||
3-Year Change | 29.74% | ||
5-Year Change | 38.39% | ||
Fundamentals | |||
Shares Outstanding | 101.6M | ||
Total Assets | $5.4B | ||
Market Cap | $14.4B | ||
Enterprise Value | $14.0B | ||
Period: QTR TTM FY | |||
Revenue | $954.3M | ||
Net Income | $144.4M | ||
Free Cash Flow | $128.6M | ||
EBIT | $165.1M | ||
EBITDA | $181.5M | ||
Net Working Capital | $763.0M | ||
EPS | $1.39 | ||
Enterprise Value/EBITDA | 77 | ||
Enterprise Value/Revenue | 15 | ||
P/B | 4 | ||
P/E | 102 | ||
PEG | -4 | ||
Price/Free Cash Flow | 112 | ||
Price/Operating Cash Flow | 105 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue